Saab Deployable Health Capability achieves major delivery milestone
Saab Australia’s deployable health project JP2060 Phase 3 delivered 131 separate modules that were accepted by the Commonwealth, thereby achieving Contract Material Release 1.
The modules, which range from complex deployable surgical modules to training equipment, will now be tested by Defence as they progress towards Initial Operating Capability later this year.
Under the AUD 384 million JP2060-3 project, Saab will provide Defence with more than 550 health modules to deliver clinical care, including surgery, advanced medical imaging, trauma and intensive care services, categorised as NATO Role 1 to 3.
Saab will manage and maintain the equipment at its recently established Deployable Health Capability Support Centre (DHCSC) in Ipswich, which is now fully operational and will be utilised to provide ongoing training.
“I’m pleased the project has reached this important milestone and Saab looks forward to continuing to work closely with the Commonwealth to deliver the full JP2060-3 capability,” said Saab Australia Managing Director, Andy Keough CSC.
“The advanced deployable health capability that Saab is delivering will enable the Australian Defence Force to rapidly deploy lifesaving medical equipment, facilities and services to locations across Australia and the world.”
Saab has developed a world-leading sovereign Australian capability in the deployable health and infrastructure domain, including the establishment of the Deployable Health Capability Centre of Excellence (CoE) in Melbourne.
Through the CoE, Saab is partnering with industry and academia to further develop deployable health solutions and is currently pursuing export opportunities in Europe, the Middle East and Asia.
